Cargando…

Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary

BACKGROUND: Although respiratory symptoms are characteristic features of COPD, there is no standardised method for quantifying their severity in stable disease. OBJECTIVE: To evaluate the EXACT-Respiratory Symptom (E-RS) measure, a daily diary comprising 11 of the 14 items in the Exacerbations of Ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leidy, N K, Sexton, C C, Jones, P W, Notte, S M, Monz, B U, Nelsen, L, Goldman, M, Murray, L T, Sethi, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995276/ https://www.ncbi.nlm.nih.gov/pubmed/24595666 http://dx.doi.org/10.1136/thoraxjnl-2013-204428

Ejemplares similares

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
por: Buhl, Roland, et al.
Publicado: (2015)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments
por: Garcia-Aymerich, Judith, et al.
Publicado: (2021)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
por: Frith, Peter A, et al.
Publicado: (2015)

High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study
por: Hedsund, Caroline, et al.
Publicado: (2022)

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
por: Maddocks, Matthew, et al.
Publicado: (2016)

The ‘ABC’ of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians – a systematic review
por: Howarth, Timothy P, et al.
Publicado: (2023)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

Efficacy of different respiratory supports to prevent hypoxia during flexible bronchoscopy in patients of COPD: a triple-arm, randomised controlled trial
por: Sharma, Vinod Kumar, et al.
Publicado: (2023)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

ACE and response to pulmonary rehabilitation in COPD: two observational studies
por: Kon, Samantha S C, et al.
Publicado: (2017)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

Are clinical risk scores for COPD useful?
por: Quint, Jennifer K
Publicado: (2015)

The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference
por: Nolan, Claire M, et al.
Publicado: (2016)

Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score
por: Echevarria, Carlos, et al.
Publicado: (2019)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
por: Stone, Philip W, et al.
Publicado: (2022)

Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis
por: Fermont, Jilles M, et al.
Publicado: (2019)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
por: Echevarria, C, et al.
Publicado: (2017)

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
por: Marcon, Alessandro, et al.
Publicado: (2018)

High-intensity non-invasive ventilation during exercise-training versus without in people with very severe COPD and chronic hypercapnic respiratory failure: a randomised controlled trial
por: Schneeberger, Tessa, et al.
Publicado: (2023)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
por: Moll, Matthew, et al.
Publicado: (2020)

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
por: Lewis, Amy, et al.
Publicado: (2011)

FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease
por: Alderawi, Amr, et al.
Publicado: (2020)

Use, utility and methods of telehealth for patients with COPD in England and Wales: a healthcare provider survey
por: Al Rajeh, Ahmed, et al.
Publicado: (2019)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tspfp305et5punv8bput3qds53